Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objectives of this study are: • To determine the antiviral efficacy of combination treatment with sofosbuvir/GS-5885 fixed-dose combination ± RBV as measured by the proportion of subjects with SVR 12 weeks after discontinuation of therapy (SVR12). • To evaluate the safety and tolerability of each treatment regimen as assessed by review of the accumulated safety data
Critère d'inclusion
- Chronic Genotype 1 Hepatitis C Virus Infection